Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.

Lamarche B, Lemieux I, Després JP.

Diabetes Metab. 1999 Sep;25(3):199-211. Review.

PMID:
10499189
2.
3.

Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study.

Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD, Welty TK, Lee ET, Krauss RM, Howard BV.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2713-20.

4.

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

Tchernof A, Lamarche B, Prud'Homme D, Nadeau A, Moorjani S, Labrie F, Lupien PJ, Després JP.

Diabetes Care. 1996 Jun;19(6):629-37.

PMID:
8725863
6.
7.

Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease.

Koba S, Hirano T, Kondo T, Shibata M, Suzuki H, Murakami M, Geshi E, Katagiri T.

Am Heart J. 2002 Dec;144(6):1026-35.

PMID:
12486427
8.

Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.

Chapman MJ, Guérin M, Bruckert E.

Eur Heart J. 1998 Feb;19 Suppl A:A24-30. Review.

PMID:
9519339
9.
10.
12.
13.

The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men.

Vohl MC, Tchernof A, Dionne FT, Moorjani S, Prud'homme D, Bouchard C, Nadeau A, Lupien PJ, Després JP.

Diabetes. 1996 Oct;45(10):1405-11.

PMID:
8826978
14.

The role of small, dense low density lipoprotein (LDL): a new look.

Packard C, Caslake M, Shepherd J.

Int J Cardiol. 2000 Jun 30;74 Suppl 1:S17-22. Review.

PMID:
10856769
15.

Pharmacologic treatment of type 2 diabetic dyslipidemia.

Moon YS, Kashyap ML.

Pharmacotherapy. 2004 Dec;24(12):1692-713. Review.

PMID:
15585439
16.

Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel.

Shepherd J, Betteridge J, Van Gaal L; European Consensus Panel.

Curr Med Res Opin. 2005 May;21(5):665-82. Review.

PMID:
15969866
17.

[Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].

Slapikas R, Luksiene D, Slapikiene B, Babarskiene MR, Grybauskiene R, Linoniene L.

Medicina (Kaunas). 2005;41(11):925-31. Lithuanian.

18.

LDL size and risk of coronary heart disease in elderly men and women.

Mykkänen L, Kuusisto J, Haffner SM, Laakso M, Austin MA.

Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2742-8.

19.

Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study).

St-Pierre AC, Bergeron J, Pirro M, Cantin B, Dagenais GR, Després JP, Lamarche B; Quebec Cardiovascular Study.

Am J Cardiol. 2003 Mar 1;91(5):555-8.

PMID:
12615259
20.

[Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].

Koba S, Hirano T, Sakaue T, Sakai K, Kondo T, Yorozuya M, Suzuki H, Murakami M, Katagiri T.

J Cardiol. 2000 Dec;36(6):371-8. Japanese.

PMID:
11190580

Supplemental Content

Support Center